CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 study
Authors
Ulus S. Akarca
Florin A. Caruntu
+19 more
Mustafa K. Celen
Manuela G. Curescu
Hans Peter Dienes
Andreas Erhardt
Selim Gurel
Benjamin Heidrich
Ramazan Idilman
Onur Keskin
Stefan Lueth
Michael P. Manns
Ingmar Mederacke
George V. Papatheodoridis
Kerstin Port
Monica N. Radu
Judith Stift
Heiner Wedemeyer
Kendal Yalcin
Cihan Yurdaydin
Stefan Zeuzem
Publication date
1 January 2012
Publisher
Wiley-Blackwell
Abstract
63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) -- NOV 09-13, 2012 -- Boston, MAWOS: 000310955601024Amer Assoc Study Liver Di
Similar works
Full text
Available Versions
Ege University Institutional Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:gcris.ege.edu.tr:11454/464...
Last time updated on 23/11/2023